SCHEMBL4976700

SCHEMBL4976700

O=C(Cc1ccccc1)N1CCc2c(ncnc2N2CCN(C3CCC3)CC2)C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
KDM4E B2RXH2 3/20 0.55
HRH3 Q9Y5N1 3/20 0.43
HRH1 P35367 2/20 0.43
ACACB O00763 1/20 0.43
ACACA Q13085 1/20 0.43
TMEM97 Q5BJF2 4/20 0.42
SIGMAR1 Q99720 4/20 0.42
P2RY12 Q9H244 1/20 0.42
PARP1 P09874 2/20 0.42
CHRM4 P08173 1/20 0.41
HTR1A P08908 1/20 0.41
CHRM5 P08912 1/20 0.41
ADRA2A P08913 1/20 0.41
ADRA2B P18089 1/20 0.41
HRH2 P25021 1/20 0.41
ADRA1D P25100 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
ADRA1A P35348 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4980177 0.85 KCNK3 (0.49) ALDH1A1KDM4EHRH3HRH1ACACB
SCHEMBL4974700 0.85 TLR7 (0.40) ALDH1A1HRH3HRH1PARP1KCNK3
SCHEMBL4982023 0.83 KCNK3 (0.43) ALDH1A1HRH3HRH1PARP1KCNK3
SCHEMBL4979872 0.83 ADORA2A (0.47) ALDH1A1KDM4EHRH3HRH1TMEM97
SCHEMBL4982028 0.83 KRAS (0.42) ALDH1A1HRH3HRH1PARP1KCNK3
SCHEMBL4982034 0.83 KRAS (0.42) ALDH1A1HRH3HRH1PARP1KCNK3
SCHEMBL4982019 0.82 ADORA2A (0.46) ALDH1A1KDM4EHRH3HRH1TMEM97
SCHEMBL4980311 0.82 KDM4E (0.46) KDM4EHRH3HRH1P2RY12PARP1
SCHEMBL4978912 0.82 KDM4E (0.55) ALDH1A1KDM4EACACBACACAPOLB
SCHEMBL4978085 0.82 KCNK3 (0.40) HRH3HRH1PARP1KCNK3KCNK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION 2008-02-28 US disclosed
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION 2008-02-28 US disclosed
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION 2008-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES HRH3, HRH4, HRH2 ALDH1A1 1142/4885KDM4E 1865/4885HRH3 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.